Penicillamine‑induced pemphigus
ORCiD
0000-0002-5447-9016
Document Type
Article
Publication Title
Journal of the American Medical Association (JAMA)
ISSN
0098-7484
Volume
247
Issue
19
DOI
10.1001/jama.1982.03320440053036
First Page
2705
Last Page
2707
Publication Date
5-21-1982
Abstract
Penicillamine therapy has been associated with a variety of autoimmune disorders, including pemphigus vulgaris and pemphigus foliaceus. The "late scaling rash" or oral ulcerations associated with penicillamine may represent the superficial erosions of early pemphigus. We describe four patients with pemphigus induced by penicillamine therapy and emphasize the "seborrhea-like" characteristics of this eruption that may obscure the diagnosis. A high prevalence (71%) of HLA-B15 is noted in the seven patients on whom HLA data are available. Early recognition is important because of the potentially fatal nature of pemphigus. The mechanism by which penicillamine induces or unmasks pemphigus and other immunologic syndromes remains to be elucidated.
Recommended Citation
Zone, J.,
Ward, J. R.,
Boyce, E. G.,
&
Schupbach, C.
(1982).
Penicillamine‑induced pemphigus.
Journal of the American Medical Association (JAMA), 247(19), 2705–2707.
DOI: 10.1001/jama.1982.03320440053036
https://scholarlycommons.pacific.edu/phs-facarticles/264